Medication Guide App

New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

February 2003

February 6

Cardizem LA (diltiazem hydrochloride) Extended-Release Tablets

Date of Approval: February 6, 2003
Company: Biovail Laboratories Incorporated
Treatment for: Hypertension, Angina Pectoris

Cardizem LA is an extended-release formulation of diltiazem for indicated for the once-daily treatment of hypertension and for the management of chronic stable angina.

February 26

Oxytrol (oxybutynin) Transdermal System

Date of Approval: February 26, 2003
Company: Watson Labs
Treatment for: Overactive Bladder

Oxytrol (oxybutynin) is a transdermal therapy used to treat overactive bladder (OAB), with symptoms of urge urinary incontinence, urgency and frequency.

April 5

Cardizem LA (diltiazem hydrochloride)

New Indication Approved: April 2, 2004

Hide
(web5)